Our lawyers have experience specifically relevant to stem cell research, funding and regulation.  They regularly assist stem cell companies and research institutions with the complicated regulatory and transactional issues involved in U.S. and multi-national stem cell research.  As a result, our lawyers understand specific stem cell issues in context and can apply the nuances of law and regulation emerging in the stem cell area.  We have recently been retained by a prominent legal publisher to prepare their primary volume on stem cell issues.  We regularly serve as panelists at stem cell conferences.  And we serve as commentators on stem cell issues in national legal publications.  Furthermore, through the interdisciplinary efforts of our Life Sciences group and our Health Care group, our clients, from start-ups to Fortune 100 companies, benefit from the experience, knowledge, and dedication of lawyers who understand stem cell issues within broader industry contexts.

K&L Gates has the ability to bring together knowledgeable scientific, legal and public policy specialists as necessary to meet the needs to those involved in stem cell research, development and commercialization.  Our experts include lawyers with advanced scientific degrees and "bench" research experience who understand the legal issues of the client and the role of the specialist in helping the client achieve his or her goal within the complex rules surrounding this area of science.  When necessary, our public policy professionals interface with legislators and governmental regulators to affect debate and funding decisions.  They have experience specific to stem cell issues.  This differentiates us from other firms.  We do not consider the client's problem as an academic exercise.  We pride ourselves in our ability to see the big picture, never losing sight of the fact that legal advice and business activities form a seamless whole in which a single change or action may have many consequences, both intended and unintended.

Because stem cell related activities cross many scientific, business and governmental disciplines, a team approach is required to meet the needs of those working with stem cell technology.  Our lawyers regularly work in the regulatory, intellectual property, financial, insurance, corporate, litigation, life sciences and health care sectors, in jurisdictions around the globe, to provide our clients with the advice necessary for them to conduct their businesses while minimizing their risks and maximizing their returns.  This team approach requires lawyers in many specialties and in many locations to interact in an efficient and cost-effective manner. 

As an example, lawyers in our corporate group work closely with our intellectual property lawyers to counsel start-up clients in organizing their businesses, recognizing, protecting and defending their inventions, as well as obtaining funding. Regulatory lawyers in our Food and Drug group include former members of the Food and Drug Administration and the health professions, and together with our public policy professionals are skilled in negotiating with federal laboratories and federal agencies such as the Food and Drug Administration and the National Institutes of Health.

Stem cell technology is potentially so important that stem cell facilities have been set up around the world.  The issues faced in the U.S. by the stem cell community are the same issues that have been raised globally.  Only a firm with a world-wide reach can provide advice that not only takes into consideration U.S. laws but the impact of laws of other jurisdictions.  K&L Gates is such a firm.